Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Denmark
/
Healthcare
/
NNIT
NNIT
NNIT
Digital Transformation And Life Sciences Demand Will Expand Global Markets
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
24 Aug 25
Updated
24 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
DKK 90.00
31.2% undervalued
intrinsic discount
24 Aug
DKK 61.90
1Y
-39.2%
7D
-3.4%
Loading
1Y
-39.2%
7D
-3.4%
Author's Valuation
DKK 90.0
31.2% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
DKK 90.0
31.2% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-304m
3b
2014
2017
2020
2023
2025
2026
2028
Revenue DKK 2.4b
Earnings DKK 263.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.51%
Healthtech revenue growth rate
4.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.43%
Calculation
DKK 262.96m
Earnings '28
x
9.90x
PE Ratio '28
=
DKK 2.60b
Market Cap '28
DKK 2.60b
Market Cap '28
/
24.89m
No. shares '28
=
DKK 104.62
Share Price '28
DKK 104.62
Share Price '28
Discounted to 2025 @ 6.44% p.a.
=
DKK 86.77
Fair Value '25